Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mölgaard

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Lakartidningen|October 5, 1988
[Therapeutic possibilities of a newly registered lipid suppressor]J Mölgaard, A G Olsson
European Journal of Respiratory Diseases|December 1, 1980
Development of late asthmatic reactions after allergen or exercise challenge testsR Dahl, J Mölgaard Henriksen
Advances in Experimental Medicine and Biology|January 1, 1990
Relations between smoking, food intake and plasma lipoproteinsA G Olsson, J Mölgaard
Advances in Experimental Medicine and Biology|January 1, 1990
Apolipoprotein profiles in randomly selected smokers and matched controlsJ Mölgaard, A G Olsson
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HyperlipidaemiaA G Olsson, J Mölgaard
Lakartidningen|July 12, 1989
[Does modified LDL cholesterol trigger the atherosclerotic process?]J Mölgaard, J Johansson
Lakartidningen|June 26, 1991
[High density lipoprotein prevents coronary heart disease]J Johansson, J Mölgaard
Atherosclerosis|December 1, 1991
Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemiaJ Johansson, J Mölgaard, A G Olsson
European Journal of Clinical Pharmacology|January 1, 1989
Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemiaJ Mölgaard, H von Schenck, A G Olsson
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudicationB Ziedén, J Mölgaard, A G Olsson
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Lakartidningen|October 5, 1988
[Therapeutic possibilities of a newly registered lipid suppressor]J Mölgaard, A G Olsson
European Journal of Respiratory Diseases|December 1, 1980
Development of late asthmatic reactions after allergen or exercise challenge testsR Dahl, J Mölgaard Henriksen
Advances in Experimental Medicine and Biology|January 1, 1990
Relations between smoking, food intake and plasma lipoproteinsA G Olsson, J Mölgaard
Advances in Experimental Medicine and Biology|January 1, 1990
Apolipoprotein profiles in randomly selected smokers and matched controlsJ Mölgaard, A G Olsson
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HyperlipidaemiaA G Olsson, J Mölgaard
Lakartidningen|July 12, 1989
[Does modified LDL cholesterol trigger the atherosclerotic process?]J Mölgaard, J Johansson
Lakartidningen|June 26, 1991
[High density lipoprotein prevents coronary heart disease]J Johansson, J Mölgaard
Atherosclerosis|December 1, 1991
Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemiaJ Johansson, J Mölgaard, A G Olsson
European Journal of Clinical Pharmacology|January 1, 1989
Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemiaJ Mölgaard, H von Schenck, A G Olsson
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudicationB Ziedén, J Mölgaard, A G Olsson
Pageof 3